よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


【参考資料4】抗微生物薬適正使用の手引き 第三版 本編 (100 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_45318.html
出典情報 厚生科学審議会 感染症部会 薬剤耐性(AMR)に関する小委員会 抗微生物薬適正使用(AMS)等に関する作業部会(第6回 11/19)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

抗微生物薬適正使用の手引き

第三版

34. Shaikh N, Swaminathan N, Hooper EG. Accuracy and precision of the signs and symptoms
of streptococcal pharyngitis in children: a systematic review. The Journal of pediatrics
2012;160:487-93.e3.
35. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in
adults in the emergency room. Medical decision making : an international journal of the
Society for Medical Decision Making. 1981;1(3):239-246.
36. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and
management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases
Society of America. Clinical infectious diseases : an official publication of the Infectious
Diseases Society of America. Nov 15 2012;55(10):1279-1282.
37. Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci.
Clinical microbiology reviews. 2004;17:571-80.
38. Ezike EN, Rongkavilit C, Fairfax MR, Thomas RL, Asmar BI. Effect of using 2 throat swabs
vs 1 throat swab on detection of group A streptococcus by a rapid antigen detection test.
Archives of pediatrics & adolescent medicine. May 2005;159(5):486-490.
39. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for
the management of pharyngitis in children and adults. JAMA. Apr 07 2004;291(13):15871595.
40. Catanzaro FJ, Stetson CA, Morris AJ, et al. The role of the streptococcus in the
pathogenesis of rheumatic fever. The American journal of medicine. Dec 1954;17(6):749756.
41. Brink WR, Rammelkamp CH, Jr., Denny FW, Wannamaker LW. Effect in penicillin and
aureomycin on the natural course of streptococcal tonsillitis and pharyngitis. The American
journal of medicine. Mar 1951;10(3):300-308.
42. Gerber MA. Comparison of throat cultures and rapid strep tests for diagnosis of streptococcal
pharyngitis. The Pediatric infectious disease journal. Nov 1989;8(11):820-824.
43. Bisno AL, et al. Practice guidelines for the diagnosis and management of group A
streptococcal pharyngitis. Infectious Diseases Society of America. Clinical infectious
diseases : an official publication of the Infectious Diseases Society of America. Jul 15
2002;35(2):113-125.
44. 小児呼吸器感染症診療ガイドライン作成委員会. 小児呼吸器感染症診療ガイドライン 2017.
協和企画; 2016.
45. Iijima H, Kubota M, Ogimi C. Clinical characteristics of pediatric patients with COVID-19
between Omicron era vs. pre-Omicron era. J Infect Chemother. 2022 Nov;28(11):1501-1505.
46. Lennon DR, Farrell E, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily
penicillin V in group A beta-haemolytic streptococcal pharyngitis. Archives of disease in
childhood. Jun 2008;93(6):474-478.
47. Clegg HW, Ryan AG, Dallas SD, et al. Treatment of streptococcal pharyngitis with once-daily
compared with twice-daily amoxicillin: a noninferiority trial. The Pediatric infectious disease
journal. Sep 2006;25(9):761-767.
48. Altamimi S, Khalil A, Khalaiwi KA, Milner RA, Pusic MV, Al Othman MA. Short-term lategeneration antibiotics versus longer term penicillin for acute streptococcal pharyngitis in
children. Cochrane Database Syst Rev. Aug 15 2012(8):Cd004872.
100